Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for infiltrating ureter transitional cell carcinoma has been reported in the published literature.
No clinical trials have been registered for infiltrating ureter transitional cell carcinoma.
6 publications have been identified in PubMed for infiltrating ureter transitional cell carcinoma. Research spans Review / Meta-Analysis (33%), Case Report / Case Series (33%), and Diagnostic / Biomarker (17%).
Yasrab M (2025). [PMID: 39812925](https://pubmed.ncbi.nlm.nih.gov/39812925/). *Emerg Radiol*. [Review / Meta-Analysis]
Ghosh S (2025). [PMID: 39537307](https://pubmed.ncbi.nlm.nih.gov/39537307/). *Urol Clin North Am*. [Review / Meta-Analysis]
Al-Bitar A (2025). [PMID: 40534730](https://pubmed.ncbi.nlm.nih.gov/40534730/). *Case Rep Oncol*. [Case Report / Case Series]
Guan B (2025). [PMID: 40187951](https://pubmed.ncbi.nlm.nih.gov/40187951/). *Urol Oncol*. [Epidemiology / Natural History]
Ortiz-Rey JA (2024). [PMID: 37525552](https://pubmed.ncbi.nlm.nih.gov/37525552/). *Int J Surg Pathol*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 7:50 AM UTC